Source:http://linkedlifedata.com/resource/pubmed/id/17940134
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2007-12-27
|
pubmed:abstractText |
Oseltamivir (Tamiflu, Roche, Nutley, NJ), an ester-type prodrug of the anti-influenza drug Ro 64-0802 (oseltamivir carboxylate), has been reported to be associated with neuropsychiatric side effects, which are likely to be caused by distribution of oseltamivir and/or its metabolite into the central nervous system. Enhanced toxicity and brain distribution of oseltamivir in unweaned rats led us to hypothesize that the low level of distribution of oseltamivir and/or Ro 64-0802 in adult brain was caused by the presence of a specific efflux transporter at the blood-brain barrier. We examined the possible role of P-glycoprotein (P-gp) as the determinant of brain distribution of oseltamivir and Ro 64-0802 both in vitro using LLC-GA5-COL150 cells, which overexpress human multidrug resistance protein 1 P-gp on the apical membrane, and in vivo using mdr1a/1b knockout mice. The permeability of oseltamivir in the basal-to-apical direction was significantly greater than that in the opposite direction. The directional transport disappeared on addition of cyclosporin A, a P-gp inhibitor. The brain distribution of oseltamivir was increased in mdr1a/1b knockout mice compared with wild-type mice. In contrast, negligible transport of Ro 64-0802 by P-gp was observed in both in vitro and in vivo studies. These results show that oseltamivir, but not Ro 64-0802, is a substrate of P-gp. Accordingly, low levels of P-gp activity or drug-drug interactions at P-gp may lead to enhanced brain accumulation of oseltamivir, and this may in turn account for the central nervous system effects of oseltamivir observed in some patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ATP-Binding Cassette Transporters,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Oseltamivir,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/P-glycoprotein 2,
http://linkedlifedata.com/resource/pubmed/chemical/multidrug resistance protein 3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1521-009X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6-9
|
pubmed:meshHeading |
pubmed-meshheading:17940134-ATP-Binding Cassette Transporters,
pubmed-meshheading:17940134-Animals,
pubmed-meshheading:17940134-Antiviral Agents,
pubmed-meshheading:17940134-Blood-Brain Barrier,
pubmed-meshheading:17940134-Cell Line,
pubmed-meshheading:17940134-Cell Membrane Permeability,
pubmed-meshheading:17940134-Cloning, Molecular,
pubmed-meshheading:17940134-Humans,
pubmed-meshheading:17940134-Male,
pubmed-meshheading:17940134-Mice,
pubmed-meshheading:17940134-Mice, Knockout,
pubmed-meshheading:17940134-Oseltamivir,
pubmed-meshheading:17940134-P-Glycoproteins,
pubmed-meshheading:17940134-Tissue Distribution
|
pubmed:year |
2008
|
pubmed:articleTitle |
Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein.
|
pubmed:affiliation |
Faculty of Pharmacy, Takasaki University of Health and Welfare, Takasaki, Gunma, Japan.
|
pubmed:publicationType |
Journal Article
|